Vincent Vultaggio, PAO and PFO of Zentalis Pharmaceuticals ($ZNTL), sold shares on the open market five times in the last year, totaling about $105 thousand. His most recent sale occurred on February 10, 2026. These sales rank 9,491st among 11,678 insiders in our database, where the average is $8.6 million across roughly 6.4 transactions per insider. Vultaggio made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 6, 2026 | Zentalis Pharmaceuticals, Inc. | $ZNTL | Vultaggio Vincent | PAO and PFO | S | Common Stock | 29951 | $2.43 | 156,779.0000 | 72,250,779 | 16.04% | 0.04% |
| Feb. 10, 2026 | Zentalis Pharmaceuticals, Inc. | $ZNTL | Vultaggio Vincent | PAO and PFO | S | Common Stock | 6894 | $2.42 | 146,506.0000 | 72,250,779 | 4.49% | 0.01% |
| Feb. 9, 2026 | Zentalis Pharmaceuticals, Inc. | $ZNTL | Vultaggio Vincent | PAO and PFO | S | Common Stock | 3379 | $2.39 | 153,400.0000 | 72,250,779 | 2.16% | 0.00% |
| Feb. 2, 2026 | Zentalis Pharmaceuticals, Inc. | $ZNTL | Vultaggio Vincent | PAO and PFO | S | Common Stock | 2540 | $2.55 | 187,286.0000 | 72,250,779 | 1.34% | 0.00% |
| Feb. 3, 2026 | Zentalis Pharmaceuticals, Inc. | $ZNTL | Vultaggio Vincent | PAO and PFO | S | Common Stock | 556 | $2.52 | 186,730.0000 | 72,250,779 | 0.30% | 0.00% |
| Jan. 8, 2026 | Zentalis Pharmaceuticals, Inc. | $ZNTL | Vultaggio Vincent | PAO and PFO | A | Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 72,250,779 | 9999.99% | 0.14% |
| Feb. 3, 2025 | Zentalis Pharmaceuticals, Inc. | $ZNTL | Vultaggio Vincent | PAO and Interim PFO | A | Common Stock | 158586 | $0.00 | 192,441.0000 | 0 | 468.43% | 0.00% |
| Feb. 3, 2025 | Zentalis Pharmaceuticals, Inc. | $ZNTL | Vultaggio Vincent | PAO and Interim PFO | S | Common Stock | 2615 | $1.71 | 189,826.0000 | 0 | 1.36% | 0.00% |
| Feb. 3, 2025 | Zentalis Pharmaceuticals, Inc. | $ZNTL | Vultaggio Vincent | PAO and Interim PFO | A | Stock Option (Right to Buy) | 35633 | $0.00 | 35,633.0000 | 0 | 9999.99% | 0.00% |
| Oct. 4, 2024 | Zentalis Pharmaceuticals, Inc. | $ZNTL | Vultaggio Vincent | Principal Accounting Officer | S | Common Stock | 1603 | $3.18 | 33,855.0000 | 0 | 4.52% | 0.00% |